Newsletters

Dear All, Regular readers will be aware of the global conversation now happening around the threat arising from the potential ...

Dear All, In a paper that is clearly a labor of love (1,032 references!), Mark Butler and Robert Capon have ...

Dear All, Our colleagues in Europe have been busy! Along with yesterday’s announcement about transferrable exclusivity vouchers, we also had ...

Dear All, There are more details yet to come, but the EU Council (“the Council”) and the EU Parliament (EP) ...

Note: As always, please use the copy of the newsletter posted at https://amr.solutions/ if you have trouble with links in this ...

Dear All, The 8 Dec 2025 newsletter entitled “Phage therapy: Regulatory perspectives from TATFAR” generated a fair bit of commentary! ...

Dear All, Integrating perspectives from EC HERA, EMA, Health Canada, Norway, UK MHRA, US FDA, and US NIH, the Transatlantic ...

Dear All, On 26 Nov 2026, the Antimicrobial Resistance Surveillance & Research Initiative (AMRSRN) of the Indian Council on Medical Research ...

Dear All, Recently posted, six concepts were approved for FY 2027 funding at the September 2025 meeting of NIAID’s Division of Microbiology and ...

Note: World Antibiotic Awareness Week begins tomorrow and there are multiple updates to the meeting calendar … please look for ...

Dear All, I’ve written in the past about the creative work done by the Milken Institute on health care financing ...

Dear All, I wrote in the 4 Oct 2025 newsletter about WHO’s updated reviews of antibacterial therapeutics and diagnostics. Team WHO have ...

Dear All, When I wrote earlier this year (23 Jan 2025 newsletter) that the January 2025 PACCARB meeting (Presidential Advisory ...

Dear All, I wrote previously (23 Sep 2025 newsletter, “EU’s €253 million, 10-year One Health AMR (OHAMR) Initiative”) about OHAMR (European ...

Dear All (and with thanks to Frédéric Peyrane for leading on this newsletter): You will know that we eagerly watching the ...

Dear All, Earlier this year (20 Apr 2025 newsletter), Vivli announced their 2025 AMR Surveillance Data Challenge. Funded by Johnson ...

Dear All, WHO have just (2 Oct 2025) released a pair of reports on therapeutics and diagnostics for bacterial pathogens, ...

Dear All, PACE (Pathways to Antimicrobial Clinical Efficacy), a large UK-based public-private funder, have announced a £6 million funding round ...

Dear All, The EU have today announced the European Partnership on One Health AMR (OHAMR), a major AMR funding initiative ...